Manufactures agrochemicals on a B2B basis with around 90,000 MTPA of installed capacity, operating from units near Jaipur, Rajasthan. Has backward integrated into technical manufacturing, having started production of Pretilachlor Technical herbicide and the intermediate PEDA at its existing facilities, and is expanding 2,4-D herbicide capacity fourfold to 10,000 MT. Plans to commission a fourth technical manufacturing unit at Gidani by Q2 FY27 with ₹250 million capex, and has signed an MOU for land at Dahej for a fifth plant. FY26 revenue was ₹637.775 crore with EBITDA margin of 10.6% and net profit of ₹35.284 crore. Raw materials account for 79.7% of revenue, with employee cost at 2.4%, other opex at 11.2%, depreciation at 1.7% and capex at 6.1% of revenue. Exports contributed around 2% of revenue in FY26, with the company targeting 20% by FY29. Listed on NSE and BSE on October 8, 2025 after raising ₹192.84 crore through an IPO in October 2025; CARE Ratings upgraded the credit rating from BBB to BBB+ in Q4 FY26. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Technical-grade agrochemical manufacturing, Domestic B2B sales, Export sales. Asset-heavy, B2B agrochemical manufacturer with backward integration into technicals.
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 638 |
| EBITDA (ex other income) | 64 |
| margin % | 10.0 |
| Owners' profit | 35 |
| EPS, as reported (₹) | 6.50 |
| ROE % · ROCE % | 11.4 · 17.2 |
| Debt / equity (x) | 0.31 |
| Cash from operations | (70) |
| Capex | (39) |
| ₹ crore | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|
| Revenue | 169 | 213 | 133 | 124 | 330 |
| Profit before tax | 13 | 21 | 4 | 10 | 30 |
| Net profit | 9 | 16 | 3 | 7 | 23 |
| EPS (₹) | 1.99 | 3.53 | 0.47 | 1.05 | 3.50 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 48,414 | 23.7 | 1.17 | 6.5 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 34,337 | 29.4 | 3.06 | 16.2 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 23,762 | 41.0 | 7.00 | 29.6 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 17,895 | 26.0 | 6.03 | — | 23.2 | 27.3 | — | 22.7 |
| SHARDA CROPCHEM LTD. | 6,910 | 11.0 | 2.20 | 5.7 | 21.7 | 25.2 | 17.1 | 20.5 |
| DHANUKA AGRITECH LTD | 4,359 | 14.9 | 3.11 | 9.7 | 21.2 | 27.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 29 Aug 2026 · Advance Agrolife to hold investor meeting with Equirus Capital on Sept 1 | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Notice of 24th AGM and E-Voting Information for Advance Agrolife | compliance | minimal | — | — |
| 26 Aug 2026 · 24th AGM Notice and FY26 Annual Report filed with exchanges | board shareholder meetings | low | — | — |
| 26 Aug 2026 · Advance Agrolife 24th AGM on Sep 18, 2026; FY25-26 annual report filed | board shareholder meetings | low | — | — |
| 22 Aug 2026 · Advance Agrolife sets 24th AGM for September 18, 2026 | compliance | minimal | — | — |
| 7 Aug 2026 · Advance Agrolife publishes Q1 FY26 results in newspapers | compliance | minimal | — | — |
| 6 Aug 2026 · No deviation in use of IPO funds for June 2026 quarter | compliance | minimal | — | — |
| 6 Aug 2026 · Advance Agrolife IPO proceeds fully utilized as per object, no deviations | capital market events | medium | — | — |
| 6 Aug 2026 · Advance Agrolife Q1 FY27 Investor Presentation Revenue Doubles YoY | investor communications | medium | — | — |
| 6 Aug 2026 · Advance Agrolife Q1 FY27 PAT up 152% YoY at Rs 225.5 mn, highest ever | compliance | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| 12.7 |
| 27.4 |
| RALLIS INDIA LTD | 3,833 | 23.9 | 2.26 | 12.9 | 9.7 | 12.5 | — | 0.9 |
| NACL INDUSTRIES LIMITED | 3,709 | 310.4 | 5.43 | 45.4 | 0.7 | 1.4 | 5.9 | 11.3 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 13.9 | 20.1 | 10 of 27 | 65% |
| P/B | 2.5 | 2.4 | 15 of 28 | 48% |
| ROCE | 14.6 | 12.5 | 12 of 29 | 61% |
| ROE | 11.4 | 9.2 | 13 of 28 | 56% |
| Debt / Equity | 0.3 | 0.3 | 14 of 29 | 54% |
| EBITDA margin | 10.7 | 14.8 | 20 of 28 | 30% |
| Revenue growth | 96.0 | (0.8) | 2 of 28 | 96% |
| Profit growth | 152.2 | 18.1 | 5 of 28 | 85% |
| Market cap | 764 | 1540 | 18 of 29 | 39% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
